25 May 2013
Keywords: lobucavir, starts, phase, iii, trials, hbv, bristol-myers
Article | 11 November 1998
Bristol-Myers Squibb has started a large-scale, Phase III trial ofonce-daily, oral lobucavir in patients with chronic hepatitis B virus
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 November 1998
10 November 1998
24 May 2013
© 2013 thepharmaletter.com